rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
1997-5-12
|
pubmed:databankReference |
|
pubmed:abstractText |
In this study we determined TCR alpha and beta chain nucleotide sequences of HLA-Cw* 1601-restricted cytoxic T lymphocyte (CTL) clones obtained from the peripheral blood lymphocytes (PBL) of a melanoma patient. These clones were previously shown to be involved in the recognition of melanoma-associated antigenic epitopes SAYGEPRKL and AARAVFLAL encoded by gene MAGE-1 and BAGE respectively. All (3/3) anti-MAGE-1 CTL clones displayed TCRBV5 usage and one clonotype was found twice, > 1 year apart, in patient's PBL. Two out of three anti-BAGE CTL clones showed the same TCRAV/AJ and TCRBV/BJ combinations and differed in the alpha chain CDR3 for two residues and in the beta chain CDR3 for a single nucleotide which, however, did not change translation. These results suggest a pattern of TCR conservation in CTL selected for recognition of MAGE-1 or BAGE peptides on the autoiogous melanoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/BAGE protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/MAGEA1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Melanoma-Specific Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0953-8178
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1463-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8921424-Amino Acid Sequence,
pubmed-meshheading:8921424-Antigens, Neoplasm,
pubmed-meshheading:8921424-Clone Cells,
pubmed-meshheading:8921424-DNA, Complementary,
pubmed-meshheading:8921424-Epitopes,
pubmed-meshheading:8921424-Follow-Up Studies,
pubmed-meshheading:8921424-Gene Rearrangement, beta-Chain T-Cell Antigen Receptor,
pubmed-meshheading:8921424-Humans,
pubmed-meshheading:8921424-Melanoma,
pubmed-meshheading:8921424-Melanoma-Specific Antigens,
pubmed-meshheading:8921424-Molecular Sequence Data,
pubmed-meshheading:8921424-Neoplasm Proteins,
pubmed-meshheading:8921424-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:8921424-T-Lymphocytes, Cytotoxic
|
pubmed:year |
1996
|
pubmed:articleTitle |
Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigens.
|
pubmed:affiliation |
Division of Experimental Oncology D, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|